5.38
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MNKD Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$5.37
Aprire:
$5.39
Volume 24 ore:
3.50M
Relative Volume:
0.88
Capitalizzazione di mercato:
$1.65B
Reddito:
$248.37M
Utile/perdita netta:
$11.74M
Rapporto P/E:
107.60
EPS:
0.05
Flusso di cassa netto:
$18.24M
1 W Prestazione:
+0.94%
1M Prestazione:
+17.21%
6M Prestazione:
+8.69%
1 anno Prestazione:
-14.06%
Mannkind Corp Stock (MNKD) Company Profile
Nome
Mannkind Corp
Settore
Industria
Telefono
818-661-5000
Indirizzo
1 CASPER STREET, DANBURY, CA
Confronta MNKD con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
MNKD
Mannkind Corp
|
5.38 | 1.65B | 248.37M | 11.74M | 18.24M | 0.05 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
404.21 | 100.41B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
599.94 | 59.59B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
460.65 | 59.77B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
767.33 | 45.14B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
335.16 | 37.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Mannkind Corp Stock (MNKD) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-07-16 | Ripresa | H.C. Wainwright | Buy |
2025-04-10 | Iniziato | Mizuho | Outperform |
2025-02-10 | Iniziato | Wedbush | Outperform |
2024-12-20 | Iniziato | Wells Fargo | Overweight |
2024-12-19 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
2024-09-09 | Ripresa | Leerink Partners | Outperform |
2024-06-13 | Iniziato | Rodman & Renshaw | Buy |
2023-10-10 | Iniziato | Wedbush | Outperform |
2021-05-14 | Iniziato | RBC Capital Mkts | Sector Perform |
2019-12-24 | Iniziato | Oppenheimer | Outperform |
2019-10-25 | Iniziato | Cantor Fitzgerald | Overweight |
2019-05-14 | Iniziato | BTIG Research | Buy |
2019-03-04 | Iniziato | SVB Leerink | Outperform |
2019-02-22 | Iniziato | SVB Leerink | Outperform |
2018-02-28 | Downgrade | Maxim Group | Hold → Sell |
2017-11-01 | Downgrade | Maxim Group | Buy → Hold |
2017-10-10 | Iniziato | H.C. Wainwright | Buy |
2017-10-06 | Reiterato | Maxim Group | Buy |
2017-08-11 | Iniziato | Maxim Group | Buy |
2016-05-10 | Reiterato | Piper Jaffray | Underweight |
2016-05-10 | Reiterato | RBC Capital Mkts | Underperform |
2016-01-06 | Reiterato | Piper Jaffray | Underweight |
2016-01-06 | Reiterato | RBC Capital Mkts | Underperform |
2015-11-04 | Downgrade | RBC Capital Mkts | Outperform → Underperform |
2015-09-09 | Downgrade | Piper Jaffray | Neutral → Underweight |
2015-08-03 | Reiterato | RBC Capital Mkts | Outperform |
2015-05-11 | Downgrade | JP Morgan | Neutral → Underweight |
2015-05-11 | Reiterato | MLV & Co | Hold |
2015-04-16 | Reiterato | RBC Capital Mkts | Outperform |
Mostra tutto
Mannkind Corp Borsa (MNKD) Ultime notizie
Key metrics from MannKind Corporation’s quarterly dataCEO Change & Precise Entry and Exit Recommendations - newser.com
Is MannKind Corporation (NNFN) stock undervalued historicallyMarket Activity Summary & Daily Entry Point Trade Alerts - newser.com
Is MannKind Corporation a good long term investmentSector ETF Performance & Take Advantage of Momentum Stocks - earlytimes.in
MannKind (MNKD) Appoints New Chief Medical Officer - GuruFocus
MNKD Appoints New Chief Medical Officer to Strengthen Leadership Team - GuruFocus
MannKind appoints Ajay Ahuja as chief medical officer - Investing.com
MannKind Corporation Appoints Dr. Ajay Ahuja as Chief Medical Officer - Quiver Quantitative
MannKind Appoints Dr. Ajay Ahuja as Executive Vice President and Chief Medical Officer - Yahoo Finance
Will MannKind Corporation (NNFN) stock see insider accumulationJuly 2025 Rallies & Stock Timing and Entry Methods - newser.com
Why MannKind Corporation (NNFN) stock is trending on social mediaEntry Point & High Accuracy Swing Trade Signals - newser.com
Will a bounce in MannKind Corporation offer an exitEarnings Overview Summary & Community Verified Swing Trade Signals - newser.com
Non Tuberculous Mycobacterial Infections Market Dynamics - openPR.com
MannKind (NASDAQ:MNKD) Shares Down 5%Time to Sell? - MarketBeat
MannKind (NASDAQ:MNKD) Earns Buy Rating from HC Wainwright - MarketBeat
MannKind Corporation (NASDAQ:MNKD) Sees Significant Drop in Short Interest - MarketBeat
Insider Selling: MannKind (NASDAQ:MNKD) Insider Sells 47,000 Shares of Stock - MarketBeat
Goldman Sachs Group Inc. Sells 780,939 Shares of MannKind Corporation $MNKD - MarketBeat
MannKind (NASDAQ:MNKD) Trading Down 4.2%Should You Sell? - MarketBeat
MNKD: HC Wainwright & Co. Reiterates Buy Rating with $11 Target - GuruFocus
MannKind (MNKD) chief people officer sells $250,980 in stock By Investing.com - Investing.com UK
Insider Sell Alert: Stuart Tross Sells 47,000 Shares of MannKind Corp (MNKD) - GuruFocus
MannKind (MNKD) chief people officer sells $250,980 in stock - Investing.com
Hedge Fund Bets: Can MannKind Corporation outperform under higher oil prices2025 Earnings Surprises & AI Powered Market Entry Strategies - خودرو بانک
Hedge Fund Moves: Can MannKind Corporation stock double in the next year2025 Performance Recap & Growth Focused Entry Reports - khodrobank.com
Can MannKind Corporation outperform in the next rallyQuarterly Risk Review & Verified Swing Trading Watchlist - خودرو بانک
Weekly Recap: What is MannKind Corporations P E ratio telling usQuarterly Investment Review & Consistent Return Strategy Ideas - خودرو بانک
Analyst Calls: Can MannKind Corporation navigate macro headwindsGold Moves & Consistent Profit Trading Strategies - خودرو بانک
Jacobs Levy Equity Management Inc. Increases Stock Holdings in MannKind Corporation $MNKD - MarketBeat
Millennium Management LLC Purchases 2,375,198 Shares of MannKind Corporation $MNKD - MarketBeat
Mannkind Corp Azioni (MNKD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):